Extracorporeal Shockwave Therapy for Diabetic Foot Wounds

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

February 2, 2020

Study Completion Date

May 13, 2022

Conditions
Diabetic FootWound
Interventions
DEVICE

Extracorporeal shockwave therapy in addition to standard care

Extracorporeal shockwave therapy will be given at 120 pulses/cm2, penetration 5mm at a dose of 0.1mJ/mm2 at 5 pulses/second. Participants will receive 3 sessions of shockwave therapy in a 7-day period. Standard care as per the NICE and IWGDF guidelines.

Trial Locations (1)

HU3 2JZ

Hull and East Yorkshire Hospitals NHS Trust, Hull

All Listed Sponsors
collaborator

University of Hull

OTHER

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT04042285 - Extracorporeal Shockwave Therapy for Diabetic Foot Wounds | Biotech Hunter | Biotech Hunter